- Home
- TIL vs VGI Comparison
TIL vs VGI Comparison
Compare TIL & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- VGI
- Stock Information
- Founded
- TIL 2018
- VGI 2012
- Country
- TIL United States
- VGI United States
- Employees
- TIL N/A
- VGI N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- VGI Investment Managers
- Sector
- TIL Health Care
- VGI Finance
- Exchange
- TIL Nasdaq
- VGI Nasdaq
- Market Cap
- TIL 177.1M
- VGI 89.7M
- IPO Year
- TIL 2021
- VGI N/A
- Fundamental
- Price
- TIL $21.55
- VGI $8.00
- Analyst Decision
- TIL Buy
- VGI
- Analyst Count
- TIL 6
- VGI 0
- Target Price
- TIL $120.50
- VGI N/A
- AVG Volume (30 Days)
- TIL 145.1K
- VGI 46.0K
- Earning Date
- TIL 11-12-2025
- VGI 01-01-0001
- Dividend Yield
- TIL N/A
- VGI 12.66%
- EPS Growth
- TIL N/A
- VGI N/A
- EPS
- TIL N/A
- VGI N/A
- Revenue
- TIL N/A
- VGI N/A
- Revenue This Year
- TIL N/A
- VGI N/A
- Revenue Next Year
- TIL N/A
- VGI N/A
- P/E Ratio
- TIL N/A
- VGI N/A
- Revenue Growth
- TIL N/A
- VGI N/A
- 52 Week Low
- TIL $10.80
- VGI $6.68
- 52 Week High
- TIL $73.69
- VGI $7.99
- Technical
- Relative Strength Index (RSI)
- TIL 38.52
- VGI 53.45
- Support Level
- TIL $22.67
- VGI $7.96
- Resistance Level
- TIL $25.89
- VGI $8.09
- Average True Range (ATR)
- TIL 2.61
- VGI 0.06
- MACD
- TIL -0.62
- VGI -0.01
- Stochastic Oscillator
- TIL 10.46
- VGI 35.71
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest
Virtus Global Multi-Sector Inc is a United States based fund. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objective by applying extensive credit research to capitalize on opportunities across undervalued areas of the international bond markets.